Disease Areas News and analysis on disease research and diagnostics. Sep 29, 2022 New NIH-Funded Network Aims to Bring Precision to External Beam Radiation Treatment Premium Sep 29, 2022 Consortium Aims to Standardize IHC Biomarker Tests for Precision Medicine, Starting With HER2 Premium Sep 29, 2022 Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval Sep 29, 2022 California Governor Signs Cancer Care Equity Act Into Law Sep 28, 2022 Olema Oncology Hoping to Avoid Past Pharma Mistakes With Complete Estrogen Receptor Antagonist Premium Sep 28, 2022 Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders Premium Sep 28, 2022 Cleara Biotech Raises $2.5M to Advance Cancer Drugs Targeting 'Scarred Cell' Biomarkers Sep 27, 2022 Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers Sep 27, 2022 Telix Pharmaceuticals Begins Phase II Trial of Radiolabeled Prostate Cancer Antibody Treatment Sep 27, 2022 Optellum Raises $14M in Series A Financing Sep 27, 2022 Tavros Therapeutics Raises $7.5M to Advance Biomarker-Directed Cancer Drug Discovery Platform Sep 26, 2022 Myongji Hospital, Next&Bio Partner on Organoid-Based Precision Therapy Program Sep 26, 2022 WEHI Launches Project to Improve Genomic Data Interpretation, Precision Cancer Care in Australia Sep 23, 2022 NICE Recommends Pfizer's Ibrance Combination for HER2-Negative Breast Cancer Sep 23, 2022 In Brief This Week: Seagen, Ideaya Biosciences, Cellistic, AstraZeneca, Kinnate Biopharma Sep 23, 2022 Galecto Explores Anti-Cancer Potential of Inhibiting Fibrosis, Scarring Pathway Premium Sep 23, 2022 Caris Life Sciences to Offer Molecular Profiling Services on Flatiron Health Platform Sep 22, 2022 Universal Genetic Testing in Breast Cancer Further Supported in New Invitae-Led Study Sep 22, 2022 Revolution Medicines Begins Phase I Trial of KRAS G12C Inhibitor Sep 22, 2022 Persephone Biosciences Enrolls First Patient in Study of Microbiome Effect on Cancer Drug Response Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
